Stay tuned
Merck looks for leg up on Bristol with Keytruda's latest colorectal cancer win
Merck’s Keytruda went up against chemo in a head-to-head colorectal
Unlike FDA, European regulators refuse to clear chloroquine for COVID-19 without data
In the quest to treat COVID-19, chloroquine and hydroxychloroquine h
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Biocon has finally satisfied the FDA that its insulin production plan
Roche Canada crowdsources COVID-19 ideas in new quick-turn innovation challenge
Roche Canada is looking for a few good ideas to fight COVID-19, and i
Another Zolgensma delay is bad for Novartis in SMA but good for Biogen’s Spinraza: analyst
Novartis is still waiting for FDA guidance about what's needed to lif
Stay tuned
© 1994 - 2020 B.M. Pharmaceuticals